The present invention relates to comprising peptides for preventing or treating allergy to house dust mites, and in particular to optimal combinations of peptides for preventing or treating said allergy.

The present invention relates to a hydrochloride salt of a peptide consisting of the sequence of CPAVKRDVDLFLT (SEQ ID NO: 1) as well as its combinations with other peptides for immunosuppressive purposes.

Polypeptides which may be used for preventing or treating allergy to moulds of the Cladosporium and/or Alternaria genus have up to 30 amino acids in length and comprise: (I) the amino acid sequence: (a) GGYKAAVRPTMLE (SEQ ID NO : 35; Cla35) (b) AE V YQKLK SLTKK (SEQ ID NO: 31; Clal6) (c) VAITYASRAQGAE (SEQ ID NO:...

Pharmaceutical formulations which may be used for preventing or treating allergy to moulds of the Alternaria and/or Cladosporiumgenus comprising a pharmaceutically acceptable carrier or diluent and a polypeptide or a pharmaceutically acceptable salt thereof selected from at least three of: (a)a polypeptide comprisin...

The present invention relates to compositions comprising peptides for preventing or treating allergy to cats, and in particular to optimal combinations of peptides. [Figure 1]

The present invention relates to peptides which are formulated or engineered to prevent or reduce the formation of dimmers.

The present invention relates to compositions for preventing or treating allergy to ragweed by tolerisation. The compositions are based on combinations of peptide fragments derived from the major allergen in ragweed pollen, Amb a 1. The invention also relates to products, vectors and formulations which may be used t...

The present invention relates to compositions comprising peptides for preventing or treating allergy to birch and in particular to optimal combinations of peptides for preventing or treating said allergy.

The present invention relates to compositions comprising peptides for preventing or treating allergy to house dust mites, and in particular to optimal combinations of peptides for preventing or treating said allergy.

The present invention relates to the use of a non-reducing carbohydrate or carbohydrate derivative and at least one agent which inhibits dimer formation in a freeze-dried composition comprising at least one peptide that contains a free cysteine residue, to provide a freeze-dried composition with improved long-term s...